Artificial Intelligence-assisted Glaucoma Screening (AIAGS)

NCT03682783 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 8000

Last updated 2018-09-25

No results posted yet for this study

Summary

This study will develop an artificial intelligence (AI) program for the screening of glaucoma.

Conditions

  • Glaucoma Eye

Interventions

DIAGNOSTIC_TEST

Fundus Image

Fundus image of optic nerve

Sponsors & Collaborators

  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Haiyan Wang, Ph.D. · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2020-10-01
Completion
2021-10-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03682783 on ClinicalTrials.gov